Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis - Poll - MDSpire

Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis

  • By

  • Lidan Zhang

  • Xiaogang Hao

  • Yidan Cui

  • Wenjian Yan

  • Kun Shang

  • Xin Zhang

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis

  • by Lidan Zhang, Xiaogang Hao, Yidan Cui, Wenjian Yan, Kun Shang, Xin Zhang

  • June 11, 2026

Related Content

Association Between Delivery Method and Offspring's Risk of Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta-Analysis

Side Effects: Four Studies Worth Passing On

Kissing celiacs, Ozempic genes, Viagra for the brain, and a UTI test that actually works. This week's evidence is weird, useful, and worth your time.

Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals